Philip Mathew, Lakhtakia Sundeep, Aggarwal Rakesh, Madan Kaushal, Saraswat Vivek, Makharia Govind
Lisie Hospital, Kochi, India.
Asian Institute of Gastroenterology, Hyderabad, India.
J Clin Exp Hepatol. 2020 May-Jun;10(3):266-270. doi: 10.1016/j.jceh.2020.04.001. Epub 2020 Apr 3.
Coronavirus disease 2019 (COVID-19), which started in December 2019 in China, has resulted in a pandemic leading to significant morbidity and mortality across the globe. Although it mainly causes respiratory symptoms, respiratory failure and death due to multiorgan failure, there is evolving evidence to suggest gastrointestinal (GI) and liver involvement by this virus. Owing to this, health-care professionals taking care of GI and liver diseases are also at an increased risk of getting exposed. Hence, there is a need for protocols to be prepared to guide the handling of COVID-19 patients by the GI and liver specialists, as well as to manage the pre-existing GI and liver diseases during the ongoing pandemic. We present here the guidelines prepared jointly by the three Indian professional bodies in the field of GI diseases, namely the Society of Gastrointestinal Endoscopy of India, Indian Society of Gastroenterology, and Indian National Association for the Study of the Liver.
2019年冠状病毒病(COVID-19)于2019年12月在中国爆发,已导致全球大流行,造成了严重的发病率和死亡率。尽管它主要引起呼吸道症状、呼吸衰竭以及多器官衰竭导致的死亡,但越来越多的证据表明该病毒会累及胃肠道(GI)和肝脏。因此,照顾胃肠道和肝脏疾病患者的医护人员暴露风险也在增加。因此,需要制定方案,以指导胃肠病和肝病专家处理COVID-19患者,并在当前大流行期间管理既往存在的胃肠道和肝脏疾病。我们在此展示由印度胃肠病领域三个专业机构联合制定的指南,这三个机构分别是印度胃肠内镜学会、印度胃肠病学会和印度肝脏研究全国协会。